Literature DB >> 1838043

Lipoprotein (a) and microvascular disease in type 1 (insulin-dependent) diabetes.

P H Winocour1, D Bhatnagar, M Ishola, S Arrol, P N Durrington.   

Abstract

The influence of albuminuria and proliferative retinopathy on concentration of serum lipoprotein (a) was examined cross-sectionally in 90 Type 1 diabetic patients. Concentrations of lipoprotein (a) were less in those with normoalbuminuria (90 (8-882) (median (range] U l-1) than in those with micro- or macro-albuminuria (137 (19-1722) U l-1, p less than 0.05). The prevalence of patients whose lipoprotein (a) concentrations were greater than 200 U l-1 was also greater (45% vs 24%, p = 0.03) among patients with albuminuria, but no difference was found between the microalbuminuric and macroalbuminuric groups (53 and 41%, respectively), or between those with or without proliferative retinopathy. The present finding that lipoprotein (a) concentrations may be increased at an early stage of diabetic renal disease may in part account for the excess ischaemic heart disease associated with diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1838043     DOI: 10.1111/j.1464-5491.1991.tb01531.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  10 in total

1.  Microalbuminuria.

Authors:  P H Winocour
Journal:  BMJ       Date:  1992-05-09

2.  Serum lipoprotein(a) levels in adolescents and young adults with insulin-dependent diabetes mellitus.

Authors:  G d'Annunzio; C Gazzaruso; A Alibrandi; D Geroldi; R Lorini
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

3.  Relationship of progressively increasing albuminuria to apoprotein(a) and blood pressure in type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetic patients.

Authors:  G Jerums; T J Allen; C Tsalamandris; A Akdeniz; A Sinha; R Gilbert; M E Cooper
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

Review 4.  Dyslipidemia and diabetic retinopathy.

Authors:  Yo-Chen Chang; Wen-Chuan Wu
Journal:  Rev Diabet Stud       Date:  2013-08-10

5.  Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.

Authors:  J Q Purnell; S M Marcovina; J E Hokanson; H Kennedy; P A Cleary; M W Steffes; J D Brunzell
Journal:  Diabetes       Date:  1995-10       Impact factor: 9.461

6.  Plasma apolipoprotein (a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.

Authors:  A J Jenkins; J S Steele; E D Janus; J D Santamaria; J D Best
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

7.  Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.

Authors:  F S Nielsen; A I Voldsgaard; M A Gall; P Rossing; E Hommel; P Andersen; J Dyerberg; H H Parving
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

8.  Lipoprotein (a) and vascular disease in diabetic patients.

Authors:  R W James; M Boemi; C Sirolla; L Amadio; P Fumelli; D Pometta
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

9.  UK Prospective Diabetes Study (UKPDS). X. Urinary albumin excretion over 3 years in diet-treated type 2, (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia.

Authors: 
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

10.  Insulin sensitivity and Lp(alpha) concentrations in normoglycemic offspring of type 2 diabetic parents.

Authors:  Agathoklis Psyrogiannis; Ioannis Habeos; Venetsana Kyriazopoulou
Journal:  Lipids Health Dis       Date:  2003-10-29       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.